| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |